[Reversible hepatic encephalopathy provoked by diuretics].
D000471:Alkalosis / Q000378:metabolism; D001120:Arginine / Q000627:therapeutic use; D002740:Chlorothiazide / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects* / Q000627:therapeutic use; D004569:Electroencephalography; D004976:Ethacrynic Acid / Q000009:adverse effects; D005260:Female; D006501:Hepatic Encephalopathy / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007008:Hypokalemia / Q000378:metabolism; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000378:metabolism; D011188:Potassium / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D011189:Potassium Chloride / Q000627:therapeutic use
D004232:Diuretics; D011189:Potassium Chloride; D002740:Chlorothiazide; D001120:Arginine; D004976:Ethacrynic Acid; D011188:Potassium
Encephalopathie hépatique reversible provoquée par des diurétiques.